Stage IIIB Breast Cancer Active Not Recruiting Phase 2 Trials for Fulvestrant (DB00947)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02269670Phase II Study of Everolimus Beyond ProgressionTreatment
NCT01142401Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast CancerTreatment